Litigation Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
✉ Email this page to a colleague
H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-01-11 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Parties | MSN LABORATORIES PRIVATE LIMITED | ||
| Patents | 7,144,884; 8,476,279; 8,722,684; 8,969,355; 9,125,908; 9,125,909; 9,125,910; 9,227,946; 9,278,096; 9,861,630 | ||
| Attorneys | Alton L. Hare , III | ||
| Firms | Buchanan Ingersoll & Rooney PC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in H. Lundbeck A/S v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-04-13 | 1052 | Post Trial Brief | Invalidity of the Asserted Claims of U.S. Patent Nos. 7,144,884, 8,476,279, 9,090,575, 9,125,910 and 9,278,096…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2021-04-16 | 1061 | Letter | Noninfringement of U.S. Patent Nos. 8,722,684, 9,125,626, 9,125,910, 9,278,096, and 9,…Brief on Noninfringement of U.S. Patent Nos. 8,722,684, 9,125,626, 9,125,910, 9,278,096…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2021-08-19 | 1073 | Letter | for finding induced infringement of U.S. Patent No. 9,278,096 in this matter. GSK II confirms that an…Defendants will induce infringement of the ’096 Patent if approved, is consistent with GSK II and Federal…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2021-09-30 | 1076 | Order | U.S. Patent No. 7,144,884 ("the '884 Patent") and claims 5 and 15 of U.S . Patent No. …of U.S. Patent No. 8,722,684 ("the '684 Patent"), claims 5-7 of U .S. Patent No. 9,861,630…63 0 Patent"), claims 4, 5, and 7 of U.S. Patent No. 9,278 ,096 ("the '096 Patent"…x27;684 Patent, claims 2-7 of the ' 630 Patent, claims 4, 5, and 7 of the '096 Patent, and claim…the '684 Patent, claims 2-4 of the '630 Patent, claim 7 of the '096 Patent, and claim 6 | External link to document |
| 2018-03-27 | 15 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1; . (Noreika, Maryellen…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2019-05-14 | 250 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2 ;8,969,355 B2 ;9,227,946…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2019-05-31 | 280 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 ;8,476,279 ;8,722,684…2018 28 October 2021 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
